Chargement en cours...
Understanding and circumventing resistance to anticancer monoclonal antibodies
With the widespread use of therapeutic monoclonal antibodies in the treatment of patients with cancer, resistance to these agents has become a major issue. Preclinical models of drug action or resistance have contributed to unravel the main mechanisms of resistance, involving both tumor-associated a...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Landes Bioscience
2009
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2726592/ https://ncbi.nlm.nih.gov/pubmed/20065642 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|